1 results match your criteria: "Xi'an Daxing Hospital No. 353 Laodong North Road[Affiliation]"
Am J Transl Res
June 2024
Respiratory and Critical Care Medicine Department, Xi'an Daxing Hospital No. 353 Laodong North Road, Xi'an 710082, Shaanxi, China.
Objective: To assess the therapeutic efficacy of combining a programmed death-1 (PD-1) inhibitor with recombinant human endostatin in patients diagnosed with advanced non-small cell lung cancer (NSCLC).
Methods: We retrospectively collected data from 83 patients with advanced NSCLC who received treatment at Xi'an Daxing Hospital between May 2020 and July 2022. Among them, 42 patients were treated with a PD-1 inhibitor combined with recombinant human endostatin (observation group), while 41 patients received PD-1 inhibitor monotherapy (control group).
© LitMetric 2025. All rights reserved.